Authoritative Guidance for Temperature Stability & GDP Compliance
A curated reference library of global regulatory and industry guidance commonly used in pharmaceutical temperature excursion and stability analyses.
Global Regulatory Guidance
WHO Technical Report Series No. 961, Annex 9: Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products
Foundational WHO guidance on storage and transport requirements for temperature-sensitive pharmaceutical products.
View Official GuidanceWHO Technical Report Series No. 992, Annex 5: Guidance on good storage and distribution practices for pharmaceuticals
Updated WHO guidance supplementing TRS 961 with expanded storage and distribution practice requirements.
View Official GuidanceICH Q1A(R2): Stability Testing of New Drug Substances and Products
International harmonized guidance establishing stability testing requirements for drug registration.
View Official GuidanceICH Q1E: Evaluation of Stability Data
Guidance on statistical analysis and extrapolation of stability data to establish shelf life.
View Official GuidanceICH Q5C: Stability Testing of Biotechnological/Biological Products
Specialized stability testing guidance for biotechnology-derived and biological products.
View Official GuidanceEU Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)
European Commission guidelines establishing GDP requirements for medicinal product distribution.
View Official GuidanceHealth Canada GUI-0069: Guidelines for Temperature Control of Drug Products during Storage and Transportation
Canadian regulatory guidance on temperature control requirements during storage and transport.
View Official GuidanceFDA Guidance for Industry: ANDAs – Stability Testing of Drug Substances and Products
FDA guidance on stability testing requirements for abbreviated new drug applications.
View Official GuidancePharmacopoeial Standards
USP General Chapter <659> Packaging and Storage Requirements
Defines storage condition terminology and packaging requirements for pharmaceutical products.
View Official GuidanceUSP General Chapter <1079> Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products
Comprehensive guidance on risk management for pharmaceutical storage and transportation.
View Official GuidanceUSP General Chapter <1079.2> Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products
Defines MKT calculation methodology and application in temperature excursion analysis.
View Official GuidanceIndustry Best Practice & Technical Reports
PDA Technical Report No. 39 (Revised 2021): Guidance for Temperature-Controlled Medicinal Products - Maintaining the Quality of Temperature-Sensitive Medicinal Products through the Transportation Environment
Industry best practice for maintaining product quality during temperature-controlled transportation.
View Official GuidancePDA Technical Report No. 46 (Revised 2024): Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to End Users
Updated guidance addressing GDP requirements for final distribution to end users.
View Official GuidancePDA Technical Report No. 52: Guidance for Good Distribution Practices (GDPs) for the Pharmaceutical Supply Chain
Comprehensive GDP guidance covering the entire pharmaceutical supply chain.
View Official GuidancePDA Technical Report No. 53: Guidance for Industry: Stability Testing to Support Distribution of New Drug Products
Industry guidance on stability testing specifically supporting distribution requirements.
View Official GuidancePDA Technical Report No. 58: Risk Management for Temperature-Controlled Distribution
Risk-based approach to managing temperature-controlled pharmaceutical distribution.
View Official GuidanceISPE Good Practice Guide: Cold Chain Management
Industry guidance on establishing and managing pharmaceutical cold chain operations.
View Official GuidanceISPE Good Practice Guide: Controlled Temperature Chambers – Commissioning, Qualification, Mapping & Monitoring (2nd Edition)
Technical guidance on temperature chamber qualification and monitoring requirements.
View Official GuidanceExpert Articles
In-depth expert guidance on pharmaceutical temperature excursions, stability data interpretation, GDP deviation handling, and QA/QP review responsibilities.
Mean Kinetic Temperature in Pharmaceutical Excursion Assessment: What It Is, How It Works, and When It Matters
Learn what mean kinetic temperature is, how it summarizes cumulative thermal exposure, where it helps in excursion assessment, and why it must be interpreted with product-specific stability data.
How to Evaluate a Pharmaceutical Temperature Excursion Using Stability Data and Risk-Based Logic
A practical guide to evaluating pharmaceutical temperature excursions using logger data, approved storage conditions, stability evidence, risk-based reasoning, and quality review.
Stability Budgets Explained: How Repeated Excursions Affect Remaining Product Shelf Life
Learn what a stability budget is, why cumulative temperature exposure matters, and how repeated excursions can affect remaining shelf life, consistency, and audit readiness.
GDP Deviations and Temperature Excursions: A Practical Workflow for Investigation, Documentation, and Quality Review
A practical GDP-focused workflow for investigating temperature excursions, documenting deviations, containing risk, and preparing quality review that stands up to audit scrutiny.
The Role of QA and QP in Temperature Excursion Assessment: What Can Be Automated and What Still Requires Human Decision-Making
Understand what quality teams can automate in excursion review, what still requires QA and QP judgment, and how to design a stronger regulatory-aligned decision workflow.
These references are provided for informational purposes only. ExcursionAssess AI does not replace regulatory guidance or Quality decision-making. Final interpretation and disposition remain the responsibility of authorized Quality personnel.